Adam Levinson

1.2k total citations
27 papers, 894 citations indexed

About

Adam Levinson is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Radiation. According to data from OpenAlex, Adam Levinson has authored 27 papers receiving a total of 894 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pulmonary and Respiratory Medicine, 7 papers in Surgery and 5 papers in Radiation. Recurrent topics in Adam Levinson's work include Prostate Cancer Diagnosis and Treatment (18 papers), Prostate Cancer Treatment and Research (15 papers) and Advanced Radiotherapy Techniques (5 papers). Adam Levinson is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (18 papers), Prostate Cancer Treatment and Research (15 papers) and Advanced Radiotherapy Techniques (5 papers). Adam Levinson collaborates with scholars based in United States and Spain. Adam Levinson's co-authors include Frank A. Critz, W. Hamilton Williams, David A. Holladay, CLINTON T. HOLLADAY, James Benton, Kenneth I. Wishnow, Frederick J. Schnell, Douglas E. Johnson, David B. Samadi and Vivian Griffin and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Urology.

In The Last Decade

Adam Levinson

25 papers receiving 815 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adam Levinson United States 15 679 282 233 153 115 27 894
A. Zapatero Spain 16 683 1.0× 208 0.7× 318 1.4× 74 0.5× 65 0.6× 89 956
Robert S. Waldbaum United States 12 477 0.7× 178 0.6× 114 0.5× 199 1.3× 158 1.4× 24 660
Peter Acher United Kingdom 14 479 0.7× 112 0.4× 59 0.3× 174 1.1× 196 1.7× 35 667
Francis Lorge Belgium 10 462 0.7× 259 0.9× 41 0.2× 243 1.6× 132 1.1× 36 796
Reinhard Golz Germany 11 715 1.1× 222 0.8× 219 0.9× 76 0.5× 176 1.5× 18 848
Theresa Wolfe United States 6 742 1.1× 147 0.5× 508 2.2× 84 0.5× 61 0.5× 11 859
Torrence M. Wilson United States 16 608 0.9× 126 0.4× 302 1.3× 80 0.5× 129 1.1× 33 763
Christoph Würnschimmel Germany 17 628 0.9× 276 1.0× 13 0.1× 96 0.6× 121 1.1× 104 833
Chakiath Jose New Zealand 7 1.1k 1.7× 144 0.5× 765 3.3× 38 0.2× 76 0.7× 9 1.2k
D. Frohneberg Germany 18 709 1.0× 908 3.2× 50 0.2× 570 3.7× 274 2.4× 65 1.6k

Countries citing papers authored by Adam Levinson

Since Specialization
Citations

This map shows the geographic impact of Adam Levinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam Levinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam Levinson more than expected).

Fields of papers citing papers by Adam Levinson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam Levinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam Levinson. The network helps show where Adam Levinson may publish in the future.

Co-authorship network of co-authors of Adam Levinson

This figure shows the co-authorship network connecting the top 25 collaborators of Adam Levinson. A scholar is included among the top collaborators of Adam Levinson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam Levinson. Adam Levinson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Izadi, Hooman, Christian Atsriku, Adam Levinson, et al.. (2023). Sgr-2921, a Potent CDC7 Inhibitor, Demonstrates Significant Anti-Leukemic Responses in Patient-Derived AML Models Representing Difficult-to-Treat Disease. Blood. 142(Supplement 1). 2801–2801. 1 indexed citations
2.
Pollard, Matthew, Young Suk Kwon, Hugh J. Lavery, et al.. (2017). Heterogeneity of Outcomes in D'Amico Intermediate-Risk Prostate Cancer Patients after Radical Prostatectomy: Influence of Primary and Secondary Gleason Score. Oncology Research and Treatment. 40(9). 508–514. 5 indexed citations
3.
Lavery, Hugh J., David B. Samadi, & Adam Levinson. (2011). 76 NOT A ZERO-SUM GAME: THE ADOPTION OF ROBOTICS HAS INCREASED OVERALL PROSTATECTOMY UTILIZATION IN THE UNITED STATES. The Journal of Urology. 185(4S). 9 indexed citations
4.
Lavery, Hugh J., et al.. (2011). 145 PREOPERATIVE STATIN USE ASSOCIATED WITH LOWER PSA BUT SIMILAR HISTOPATHOLOGIC OUTCOMES. The Journal of Urology. 185(4S). 2 indexed citations
5.
Raman, Jay D., et al.. (2007). Robotic radical prostatectomy: operative technique, outcomes, and learning curve.. PubMed. 11(1). 1–7. 27 indexed citations
6.
Critz, Frank A., et al.. (2007). 1765: Outcome after Brachytherapy for Prostate Cancer with Disease Freedom Defined by an Undetectable PSA Compared with Nadir Plus 2. The Journal of Urology. 177(4S). 586–587. 1 indexed citations
7.
Samadi, David B., Adam Levinson, A. Ari Hakimi, Ridwan Shabsigh, & Mitchell C. Benson. (2006). From proficiency to expert, when does the learning curve for robotic-assisted prostatectomies plateau? The Columbia University experience. World Journal of Urology. 25(1). 105–110. 50 indexed citations
8.
Levinson, Adam, et al.. (2005). Approach to management of clinically localized prostate cancer in patients with human immunodeficiency virus. Urology. 65(1). 91–94. 34 indexed citations
9.
Critz, Frank A., et al.. (2000). SIMULTANEOUS IRRADIATION FOR PROSTATE CANCER: INTERMEDIATE RESULTS WITH MODERN TECHNIQUES. The Journal of Urology. 738–743. 10 indexed citations
10.
Critz, Frank A., W. Hamilton Williams, Adam Levinson, et al.. (2000). SIMULTANEOUS IRRADIATION FOR PROSTATE CANCER: INTERMEDIATE RESULTS WITH MODERN TECHNIQUES. The Journal of Urology. 164(3 Part 1). 738–743. 53 indexed citations
11.
Critz, Frank A., W. Hamilton Williams, James Benton, et al.. (2000). PROSTATE SPECIFIC ANTIGEN BOUNCE AFTER RADIOACTIVE SEED IMPLANTATION FOLLOWED BY EXTERNAL BEAM RADIATION FOR PROSTATE CANCER. The Journal of Urology. 163(4). 1085–1089. 140 indexed citations
12.
Critz, Frank A., W. Hamilton Williams, CLINTON T. HOLLADAY, et al.. (1999). Post-treatment PSA ≤0.2 ng/ml defines disease freedom after radiotherapy for prostate cancer using modern techniques. Urology. 54(6). 968–971. 71 indexed citations
13.
Critz, Frank A., Adam Levinson, W. Hamilton Williams, et al.. (1999). PROSTATE SPECIFIC ANTIGEN NADIR ACHIEVED BY MEN APPARENTLY CURED OF PROSTATE CANCER BY RADIOTHERAPY. The Journal of Urology. 161(4). 1199–1205. 44 indexed citations
14.
Critz, Frank A., et al.. (1999). Simultaneous Radiotherapy for Prostate Cancer: 125I Prostate Implant Followed by External-Beam Radiation. The Journal of Urology. 4(6). 1550–1551. 30 indexed citations
15.
Critz, Frank A., Adam Levinson, W. Hamilton Williams, et al.. (1997). The PSA nadir that indicates potential cure after radiotherapy for prostate cancer. Urology. 49(3). 322–326. 64 indexed citations
16.
Critz, Frank A., Adam Levinson, W. Hamilton Williams, & David A. Holladay. (1996). Prostate-specific antigen nadir: the optimum level after irradiation for prostate cancer.. Journal of Clinical Oncology. 14(11). 2893–2900. 75 indexed citations
17.
Critz, Frank A., Adam Levinson, W. Hamilton Williams, & David A. Holladay. (1996). Is an undetectable nadir PSA a reasonable goal following irradiation for prostate cancer. 557. 1 indexed citations
18.
Wishnow, Kenneth I., et al.. (1992). Stage B () transitional cell carcinoma of bladder highly curable by radical cystectomy. Urology. 39(1). 12–16. 40 indexed citations
19.
Levinson, Adam, et al.. (1991). Fibrin glue for partial nephrectomy. Urology. 38(4). 314–316. 49 indexed citations
20.
Levinson, Adam, Douglas E. Johnson, Louise C. Strong, et al.. (1990). Familial Renal Cell Carcinoma: Hereditary or Coincidental?. The Journal of Urology. 144(4). 849–851. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Zapatero Breakdown of academic impact, for papers by Robert S. Waldbaum Breakdown of academic impact, for papers by Peter Acher Breakdown of academic impact, for papers by Francis Lorge Breakdown of academic impact, for papers by Reinhard Golz Breakdown of academic impact, for papers by Theresa Wolfe Breakdown of academic impact, for papers by Torrence M. Wilson Breakdown of academic impact, for papers by Christoph Würnschimmel Breakdown of academic impact, for papers by Chakiath Jose Breakdown of academic impact, for papers by D. Frohneberg
Rankless by CCL
2026